Children who participated in the PROSPER (PROmoting School-community-university Partnerships to Enhance Resilience) program over seven years ago showed lower rates of substance abuse after…
On May 23, the U.S. Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) for the treatment of unresectable or metastatic solid tumors with the…
Low-dose intranasal oxytocin can influence how patients with autism perceive emotion, according to a study in Translational Psychiatry. Read more and access the study.
A study in Gastroenterology reports that probiotics reduces depression in patients with irritable bowel syndrome (IBS) and increases quality of life. Read more
On May 17, the U.S. Food and Drug Administration (FDA) expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis (CF), tripling the…
On May 5, the U.S. Food and Drug Administration (FDA) approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS). Read more
Patient care decisions must be made based on the current best evidence, and nurses critically appraise many kinds of research designs and their associated…
Children who participated in the PROSPER (PROmoting School-community-university Partnerships to Enhance Resilience) program over seven years ago showed lower rates of substance…
Low-dose intranasal oxytocin can influence how patients with autism perceive emotion, according to a study in Translational Psychiatry. Read more and access the study.
A study in Gastroenterology reports that probiotics reduces depression in patients with irritable bowel syndrome (IBS) and increases quality of life. Read…